Walder Wyss advised Migros on its sale of Gowoonsesang Cosmetics, a South Korean subsidiary of the MIbelle group, to L’Oréal. The transaction is expected to be completed after customary regulatory approvals. The team
Tags :sx2
Louisa Galbraith (pictured), associate at MLL since 2017 and senior associate since 2021, has been promoted to partner, effective January 2025. Additionally, Hannah Cipriano-Favre and Camillo Devecchi have been promoted to counsel, also as of January 2025. The profiles
Dekom, advised by Walder Wyss, an international AV integrator, was acquired by VR Equitypartner, together with Süd Beteiligungen. The team Walder Wyss advised the sellers on all Swiss law aspects of this transaction. The
Niederer Kraft Frey (NKF) advised Yttrium, a technology investor, on its Series B investment in Embotech, a provider of autonomous driving solutions, advised by Walder Wyss. Other investors in this funding round included Emerald Technology,
Audrey Durand, Julien Witzig, and Thomas Zweifel have been promoted to partner status at CMS Switzerland as of January 2025. The profiles Audrey Durand joined CMS in 2017 and has, until now, practiced at the firm as
Advestra advised Liberta Partner, a Munich-based multi-family office, on its acquisition of a majority stake in Avenir Group, a human resource management company headquartered in Switzerland, advised by Vischer. Furthermore, Baker McKenzie advised Migros Bank
Walder Wyss advised Bank J. Safra Sarasin on the acquisition of 100% of the shares of MIV Asset Management(MIV), a medical technology investment fund advised by Homburger. MIV will maintain its existing investment strategy and
Kellerhals Carrard advised Partners Group, one of the largest firms in the global private markets industry, on acquiring Empira Group, a real estate investment platform with EUR 14 billion in asset value, advised by Bär &
Niederer Kraft Frey (NFK) advised Martin Mucha as insolvency administrator of Auto-Kabel Group on the Swiss law aspects throughout the restructuring process, as well as on the sale to Voltaira Group, a subsidiary of FIT-Foxconn
Pestalozzi and Kellerhals Carrard both advised Adragos Pharma, a pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, in the acquisition of Baccinex, an aseptic fill-finish manufacturing based in Courroux, Jura, Switzerland. With
